Realizing the potential of long noncoding RNA as a cancer biomarker: From NGS discovery to validation with RNA in situ Hybridization
The routine detection of non-coding RNA presents a particular set of challenges since they do not have protein counterparts for antibody detection. This is why the ability to detect RNA in cancer biopsy samples is so valuable, opening up the use of lncRNA as a biomarker.